M&A Deal Summary

Ampersand Capital Partners Acquires Precision Coating

On September 20, 2021, growth capital firm Ampersand Capital Partners acquired chemicals company Precision Coating

Acquisition Highlights
  • This is Ampersand Capital Partners’ 3rd transaction in the Chemicals sector.
  • This is Ampersand Capital Partners’ 55th transaction in the United States.
  • This is Ampersand Capital Partners’ 14th transaction in Massachusetts.

M&A Deal Summary
Date 2021-09-20
Target Precision Coating
Sector Chemicals
Buyer(s) Ampersand Capital Partners
Deal Type Buyout (LBO, MBO, MBI)

Target

Precision Coating

Hudson, Massachusetts, United States
Precision Coating provides high-tolerance coating and specialized metal-finishing services to the Medtech industry. Precision Coating was founded in 1956 and is based in Hudson, Massachusetts.

Search 201,771 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Ampersand Capital Partners

Wellesley, Massachusetts, United States

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Founded 1988
PE ASSETS 3.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.

DEAL STATS #
Overall 62 of 84
Sector (Chemicals) 3 of 4
Type (Buyout (LBO, MBO, MBI)) 20 of 23
State (Massachusetts) 14 of 15
Country (United States) 55 of 69
Year (2021) 6 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-09-20 N2 Biomedical

Bedford, Massachusetts, United States

N2 Biomedical provides coating and surface treatment development and application services for implantable and other medical devices utilized in orthopedic, cardiovascular, and other healthcare end-markets. N2 Biomedical was founded in 2013 and is based in Bedford, Massachusetts.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-11-01 Biosynth

St. Gallen, Switzerland

Biosynth is a fully hybrid research products, life sciences reagents and custom synthesis and manufacturing services company with global research, manufacturing and distribution facilities. They are the supplier of choice for many in the pharmaceutical, life science, food, agrochemical, cosmetic and diagnostic sectors and manufacture and source a vast range of chemical and biochemical products. Biosynth was formed in 1965 and is based in St. Gallen, Switzerland.

Sell -
Mergr

Product

Company

Legal